Browsing by Author Pavlakis, Nick

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 125 < previous   next >
Issue DateTitleAuthor(s)Citation
2016Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancerBoyer, Michael; Clarke, Stephen; Kao, Steven; Pavlakis, Nick; Reid, Glen; van Zandwijk, Nico; Brahmbhatt, Himanshu; MacDiarmid, Jennifer; Central Clinical School: Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteClinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer, Epigenomics, vol.8, 8, 2016,pp 1079-1085
2010Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive carePavlakis, Nick; Asmis, T; Dueck, D; Gibbs, Peter; Jeffery, M; Jonker, D; Karapetis, Christos; Langer, Christine; O’Callaghan, C; Powell, E; Tu, D.; Whittom, R; Zhu, L; Northern Clinical School: MedicineComorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care, Annals of Oncology, vol.22, 1,pp 118-126
2014Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinomaBaxter, Robert; Gill, Anthony; Hugh, Thomas; Julovi, Sohel; Pavlakis, Nick; Peters, Lyndsay; Smith, Ross; Wong, Matthew; Xue, Aiqun; Samra, Jas; Northern Clinical School: Kolling Institute; Northern Clinical School: Pathology; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Medicine; Northern Clinical School: SurgeryCotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma, Clinical Cancer Research, vol.20, 10, 2014,pp 4047-4058
2014Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013Pavlakis, Nick; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: MedicineCurrent opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013, Expert Review of Anticancer Therapy, vol.14, 12, 2014,pp 1477-1493
2013Current opinion on optimal treatment for colorectal cancerPavlakis, Nick; Ackland, Stephen P.; Burge, Matthew; Cunningham, David; Haller, Daniel; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, Jeremy; Sobrero, Alberto; Tebbutt, Niall C; Northern Clinical School: MedicineCurrent opinion on optimal treatment for colorectal cancer, Expert Review of Anticancer Therapy, vol.13, 5, 2013,pp 597-611
2015Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerBoyer, Michael; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Breit, Samuel; Brown, David; Castillo, Lesley; Chatfield, Mark; Chiam, K; Daly, R; Henshall, Susan; Lee, B Y; Lee-Ng, K K Michelle; Lin, H-M; Molloy, Mark; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreCytokine profiling of docetaxel-resistant castration-resistant prostate cancer, British Journal of Cancer, vol.112, 8, 2015,pp 1340-1348
2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trialGebski, Val; Parry, M M; Pavlakis, Nick; Zannino, Diana; Dobrovic, Alexander N; Ganju, V.; Mellor, D; Strickland, A. H.; Tebbutt, Niall C; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreDocetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial, British Journal of Cancer, vol.108, 4, 2013,pp 771-774
2015Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literatureChan, David; Pavlakis, Nick; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: Medicine; Northern Clinical School: MedicineDoes the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature, PloS One, vol.10, 8, 2015,pp 1-17
2017Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: proposal for a Novel Grading Scheme with Prognostic SignificanceBailey, Dale; Clarke, Stephen; Diakos, Connie; Engel, Alexander; Eslick, Enid; Khasraw, Mustafa; Pavlakis, Nick; Roach, Paul; Samra, Jaswinder; Schembri, Geoff; Barnes, Tristan; Bernard, Elizabeth J; Chan, David; Hayes, Aimee; Hsiao, Edward; Medical Imaging and Radiation Sciences; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: Imaging; Northern Clinical School: Surgery; Northern Clinical School: MedicineDual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: proposal for a Novel Grading Scheme with Prognostic Significance, Theranostics, vol.7, 5, 2017,pp 1149-1158
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerPavlakis, Nick; Azad, Arun; Chong, Geoff; Dobrovic, Alexander; Fluck, Kate; Gebski, Val; Johns, Terrance G; Mariadason, John M; Price, Timothy; Salemi, R; Scott, Andrew M; Skrinos, Effie; Tebbutt, Niall; Weickhardt, Andrew J; Northern Clinical School: MedicineDual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer, Journal of Clinical Oncology, vol.30, 13, 2012,pp 1505-1512
2012Effect of Medical Qigong on Cognitive function, Quality of Life and a Biomarker of Inflammation in Cancer Patients: A Randomized Controlled TrialBeale, Philip; Butow, Phyllis; Clarke, Stephen; Mullan, Barbara; Oh, Byeongsang; Pavlakis, Nick; Vardy, Janette; Larkey, Linda; Lee, Myeong Soo; Rosenthal, D.; Central Clinical School: Medicine; Psychology; Northern Clinical School: Kolling Institute; Psychology; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Concord Clinical School: MedicineEffect of Medical Qigong on Cognitive function, Quality of Life and a Biomarker of Inflammation in Cancer Patients: A Randomized Controlled Trial, Supportive Care in Cancer, vol.20, 6, 2012,pp 1235-1242
2014Effects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility StudyBeale, Philip; Bell, David; Boyle, Frances; Butow, Phyllis; Clarke, Stephen; Costa, Daniel; Davis, Esther; Oh, Byeongsang; Pavlakis, Nick; Choi, SMN; Lee, MS; Rosenthal, David; Central Clinical School: Medicine; Northern Clinical School: Psychological Medicine; Northern Clinical School: Medicine; Psychology; Northern Clinical School: Kolling Institute; Psychology; School of Public Health: School of Public Health Office; Concord Clinical School: Medicine; Northern Clinical School: MedicineEffects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility Study, International Journal of Physical Medicine & Rehabilitation, vol.2, 4, 2014,pp 1-6
2012Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST studyBoyer, Michael; Pavlakis, Nick; Abell, Fiona; de Souza, Paul; Horwood, Keith; Johnston, Michael; Millward, Michael; Rischin, Danny; Stein, Brian; Central Clinical School: Medicine; Northern Clinical School: MedicineEfficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study, Asia Pacific Journal of Clinical Oncology, vol.8, 3, 2012,pp 248-254
2014EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancerCooper, Wendy Anne; Gill, Anthony; Houang, Michelle; O'Toole, Sandra; Pavlakis, Nick; Raut, Aditi; Toon, Christopher Chien; Chou, Angela; Clarkson, Adele; Mahtab, Farzin; Mead, Scott; Sioson, Loretta; Watson, Nicole; Central Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: Kolling Institute; Central Clinical School: Pathology; Northern Clinical School: Medicine; Medicine; Northern Clinical School: Kolling InstituteEGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer, Pathology, vol.46, 6, 2014,pp 501-508
2013EGFR-Targeted therapy and resistanceHasovits, Csilla; Pavlakis, Nick; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineEGFR-Targeted therapy and resistance, Cancer Forum, vol.37, 2, 2013,pp 1-5
2017Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancerPavlakis, Nick; Wong, Rachel Sze Hui; Chan, David; Herbertson, R; Li, B; Price, Timothy; Segelov, E; Smith, A; Tebbutt, Niall; Northern Clinical School: Medicine; MedicineEpidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer, Cochrane Database of Systematic Reviews, vol.2017, 6, 2017,pp 1-175
2014Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysisGebski, Val; Khasraw, Mustafa; Ameratunga, Malaka S; Broad, Adam; Pavlakis, Nick; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEpidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysis, Asia-Pacific Journal of Clinical Oncology, vol.10, 3, 2014,pp 273-278
2015Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testingCooper, Wendy Anne; Gill, Anthony; Pavlakis, Nick; Amanuel, Benhur; Christie, Michael; Diakos, Connie; Lum, Trina; McNeil, Catriona; Millward, Michael; Morey, Adrienne; O'Toole, Sandra; Peverall, Joanne; Selinger, Christina; Tran, Yen; Van Vliet, Chris; Waring, Paul; Central Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: MedicineEquivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing, Histopathology, vol.67, 5, 2015,pp 654-663
2017Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic reviewChan, David; Albertelli, Manuela; Ferone, Diego; Pavlakis, Nick; Segelov, E; Singh, Simron; Northern Clinical School: MedicineEscalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review, Endocrine, vol.57, 3, 2017,pp 366-375
2014Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesotheliomaClarke, Stephen; Harvie, Rozelle; Howell, Viive; Hudson, Amanda; Moon, Elizabeth; Pavlakis, Nick; Weir, Christopher; Klebe, Sonja; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: MedicineEstablishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma, Scientific Reports, vol.4, N/A, 2014,pp 1-11